Mar. 13, 2026
New drug shows 'stunning' results in advanced prostate cancer
VIR-5500, a T-cell engager drug, shrank tumors in men with treatment-resistant prostate cancer.
Mar. 4, 2026
Komodo Health and ZERO Prostate Cancer Announce Partnership
The collaboration aims to improve prostate cancer screening and early detection.
Mar. 3, 2026
Kidney cancer study finds belzutifan plus pembrolizumab post-surgery helps patients at high risk for relapse stay cancer-free longer
Combination therapy shows significant improvement in disease-free survival compared to standard treatment alone
Mar. 2, 2026
Microplastics Found in 90% of Prostate Cancer Tumors
Study finds double the concentration of plastic particles in cancerous tissue compared to healthy prostate tissue.
Mar. 2, 2026
Merck, Pfizer's Drug Combo 'Rewrites the Standard of Care' in Bladder Cancer
The new data shows the combo therapy significantly improved survival and treatment response in a late-stage muscle-invasive bladder cancer study.
Feb. 28, 2026
New Immunotherapy Drug Shows Promise for Advanced Prostate Cancer
VIR-5500 shrinks tumors and reduces key cancer biomarker in clinical trial
Feb. 27, 2026
Blue Earth Diagnostics Announces Positive Results from Prostate Cancer Imaging Study
Head-to-head comparison shows POSLUMA has significantly lower urinary radioactivity than piflufolastat F 18
Feb. 27, 2026
ImmVira's Oncolytic Product MVR-T3011 Expanded to BCG-Naive Bladder Cancer Patients
Preliminary data shows promising efficacy and safety in first-time use for BCG-naive patients.
